These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 3500093)
1. Species- and tissue-specific expression of human alpha 1-antitrypsin in transgenic mice. Kelsey GD; Povey S; Bygrave AE; Lovell-Badge RH Genes Dev; 1987 Apr; 1(2):161-71. PubMed ID: 3500093 [TBL] [Abstract][Full Text] [Related]
2. The human alpha-1-antitrypsin gene is efficiently expressed from two tissue-specific promotors in transgenic mice. RĂ¼ther U; Tripodi M; Cortese R; Wagner EF Nucleic Acids Res; 1987 Sep; 15(18):7519-29. PubMed ID: 3498933 [TBL] [Abstract][Full Text] [Related]
3. Widespread expression of human alpha 1-antitrypsin in transgenic mice revealed by in situ hybridization. Koopman P; Povey S; Lovell-Badge RH Genes Dev; 1989 Jan; 3(1):16-25. PubMed ID: 2785071 [TBL] [Abstract][Full Text] [Related]
4. Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin Nullmattawa gene. An insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin. Curiel D; Brantly M; Curiel E; Stier L; Crystal RG J Clin Invest; 1989 Apr; 83(4):1144-52. PubMed ID: 2539391 [TBL] [Abstract][Full Text] [Related]
5. Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264----Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion. Curiel DT; Chytil A; Courtney M; Crystal RG J Biol Chem; 1989 Jun; 264(18):10477-86. PubMed ID: 2567291 [TBL] [Abstract][Full Text] [Related]
6. Restricted tissue-specific but correct developmental expression mediated by a short human alpha 1AT promoter fragment in transgenic mice. Yull FE; Wallace RM; Clark AJ Transgenic Res; 1995 Jan; 4(1):70-4. PubMed ID: 7881464 [TBL] [Abstract][Full Text] [Related]
7. Extinction of alpha 1-antitrypsin gene expression in somatic cell hybrids: evidence for multiple controls. Bulla GA; DeSimone V; Cortese R; Fournier RE Genes Dev; 1992 Feb; 6(2):316-27. PubMed ID: 1737621 [TBL] [Abstract][Full Text] [Related]
8. A novel SV40-based vector successfully transduces and expresses an alpha 1-antitrypsin ribozyme in a human hepatoma-derived cell line. Zern MA; Ozaki I; Duan L; Pomerantz R; Liu SL; Strayer DS Gene Ther; 1999 Jan; 6(1):114-20. PubMed ID: 10341883 [TBL] [Abstract][Full Text] [Related]
9. Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals. Mornex JF; Chytil-Weir A; Martinet Y; Courtney M; LeCocq JP; Crystal RG J Clin Invest; 1986 Jun; 77(6):1952-61. PubMed ID: 3486887 [TBL] [Abstract][Full Text] [Related]
10. Characterization of a human alpha 1-antitrypsin null allele involving aberrant mRNA splicing. Laubach VE; Ryan WJ; Brantly M Hum Mol Genet; 1993 Jul; 2(7):1001-5. PubMed ID: 8364536 [TBL] [Abstract][Full Text] [Related]
11. Molecular characterisation of the defective alpha 1-antitrypsin alleles PI Mwurzburg (Pro369Ser), Mheerlen (Pro369Leu), and Q0lisbon (Thr68Ile). Poller W; Merklein F; Schneider-Rasp S; Haack A; Fechner H; Wang H; Anagnostopoulos I; Weidinger S Eur J Hum Genet; 1999 Apr; 7(3):321-31. PubMed ID: 10234508 [TBL] [Abstract][Full Text] [Related]
12. Production of glycosylated physiologically "normal" human alpha 1-antitrypsin by mouse fibroblasts modified by insertion of a human alpha 1-antitrypsin cDNA using a retroviral vector. Garver RI; Chytil A; Karlsson S; Fells GA; Brantly ML; Courtney M; Kantoff PW; Nienhuis AW; Anderson WF; Crystal RG Proc Natl Acad Sci U S A; 1987 Feb; 84(4):1050-4. PubMed ID: 3029759 [TBL] [Abstract][Full Text] [Related]
13. Tissue specific expression of the human alpha-1-antitrypsin gene in transgenic mice. Sifers RN; Carlson JA; Clift SM; DeMayo FJ; Bullock DW; Woo SL Nucleic Acids Res; 1987 Feb; 15(4):1459-75. PubMed ID: 3029716 [TBL] [Abstract][Full Text] [Related]
14. Comparison of alpha-1-antitrypsin levels and antineutrophil elastase capacity of blood and lung in a patient with the alpha-1-antitrypsin phenotype null-null before and during alpha-1-antitrypsin augmentation therapy. Wewers MD; Casolaro MA; Crystal RG Am Rev Respir Dis; 1987 Mar; 135(3):539-43. PubMed ID: 3493719 [TBL] [Abstract][Full Text] [Related]
15. Adenovirus-mediated transfer of a recombinant human alpha 1-antitrypsin cDNA to human endothelial cells. Lemarchand P; Jaffe HA; Danel C; Cid MC; Kleinman HK; Stratford-Perricaudet LD; Perricaudet M; Pavirani A; Lecocq JP; Crystal RG Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6482-6. PubMed ID: 1631146 [TBL] [Abstract][Full Text] [Related]
16. Two distinct factors interact with the promoter regions of several liver-specific genes. Hardon EM; Frain M; Paonessa G; Cortese R EMBO J; 1988 Jun; 7(6):1711-9. PubMed ID: 2844524 [TBL] [Abstract][Full Text] [Related]
17. Expression of human alpha 1 antitrypsin in murine hematopoietic cells in vivo after retrovirus-mediated gene transfer. Saylors RL; Wall DA Mol Genet Metab; 1998 Mar; 63(3):198-204. PubMed ID: 9608542 [TBL] [Abstract][Full Text] [Related]
18. Cloning and characterization of an alpha 1-antitrypsin like gene 12 KB downstream of the genuine alpha 1-antitrypsin gene. Hofker MH; Nelen M; Klasen EC; Nukiwa T; Curiel D; Crystal RG; Frants RR Biochem Biophys Res Commun; 1988 Sep; 155(2):634-42. PubMed ID: 2901833 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of a transgenic mouse model for alpha-1-antitrypsin (AAT) related liver disease. Ali R; Perfumo S; della Rocca C; Amicone L; Pozzi L; McCullagh P; Millward-Sadler H; Edwards Y; Povey S; Tripodi M Ann Hum Genet; 1994 Oct; 58(4):305-20. PubMed ID: 7864587 [TBL] [Abstract][Full Text] [Related]